Selank
At a Glance
Selank is a peptide analog discussed in anxiolytic contexts, with a body of literature that is regionally concentrated and not always easily accessible in English. One comparative clinical report (Russian-language) describes selank versus phenazepam in anxiety disorders. [PMID: 25176261]
⚠️ Research Status: Selank is not an approved medication in many jurisdictions. This page is educational and intentionally does not include protocols/dosing.
Mechanism of Action (TBD)
Mechanistic proposals vary (e.g., neuroimmune and neurotransmitter-related framing) and should be grounded in primary sources when making any specific claim.
Evidence Summary
Low Confidence Observational 3-10 YearsComparative clinical report (Russian-language) describes anxiolytic effects and tolerability outcomes in the studied setting. [PMID: 25176261]
Safety & Unknowns
- Clinical evidence quality and reporting varies by source and region.
- Safety and efficacy cannot be generalized from limited, hard-to-audit sources.
Regulatory Status
| Region | Status |
|---|---|
| United States (FDA) | Not approved |
| European Union (EMA) | Not approved |
| WADA | Check current list (status may change) |
Changelog
| Date | Change |
|---|---|
| 2026-01-23 | Added dossier and linked primary literature |